Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Central Lab Market 

5.1. COVID-19 Landscape: Central Lab Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Central Lab Market, By Product Type

8.1. Central Lab Market, by Product Type, 2023-2032

8.1.1. Genetic Services

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Biomarker Services

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Microbiology Services

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Anatomic Pathology/Histology

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Specimen Management & Storage

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Special Chemistry Services

8.1.6.1. Market Revenue and Forecast (2020-2032)

8.1.7. Clinical Research & Trial Services

8.1.7.1. Market Revenue and Forecast (2020-2032)

8.1.8. Others

8.1.8.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Central Lab Market, By End User

9.1. Central Lab Market, by End User, 2023-2032

9.1.1. Pharmaceutical Companies

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Biotechnology Companies

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Academic & Research Institutes

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Central Lab Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.1.2. Market Revenue and Forecast, by End User (2020-2032)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.1.3.2. Market Revenue and Forecast, by End User (2020-2032)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.1.4.2. Market Revenue and Forecast, by End User (2020-2032)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.2.2. Market Revenue and Forecast, by End User (2020-2032)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.2.3.2. Market Revenue and Forecast, by End User (2020-2032)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.2.4.2. Market Revenue and Forecast, by End User (2020-2032)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.2.5.2. Market Revenue and Forecast, by End User (2020-2032)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.2.6.2. Market Revenue and Forecast, by End User (2020-2032)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.3.2. Market Revenue and Forecast, by End User (2020-2032)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.3.3.2. Market Revenue and Forecast, by End User (2020-2032)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.3.4.2. Market Revenue and Forecast, by End User (2020-2032)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.3.5.2. Market Revenue and Forecast, by End User (2020-2032)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.3.6.2. Market Revenue and Forecast, by End User (2020-2032)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.4.2. Market Revenue and Forecast, by End User (2020-2032)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.4.3.2. Market Revenue and Forecast, by End User (2020-2032)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.4.4.2. Market Revenue and Forecast, by End User (2020-2032)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.4.5.2. Market Revenue and Forecast, by End User (2020-2032)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.4.6.2. Market Revenue and Forecast, by End User (2020-2032)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.5.2. Market Revenue and Forecast, by End User (2020-2032)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.5.3.2. Market Revenue and Forecast, by End User (2020-2032)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

10.5.4.2. Market Revenue and Forecast, by End User (2020-2032)

Chapter 11. Company Profiles

11.1. ACM Global Central Lab

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Barc Lab (Cerba Research)

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Bioscientia (Sonic Healthcare)

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Celerion

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. CIRION BioPharma Research

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Clinical Reference Laboratory

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Lab Corp

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Eurofins Central Laboratory

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Frontage Laboratories, Inc

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. icon central labs

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms